ER study: haloperidol vs olanzapine for cannabis sickness
NCT ID NCT07246187
First seen Jan 06, 2026 · Last updated May 09, 2026 · Updated 19 times
Summary
This study compares two medications, haloperidol and olanzapine, to see which one better relieves nausea, vomiting, and belly pain in people with cannabinoid hyperemesis syndrome (CHS) — a condition caused by heavy, long-term cannabis use. About 114 adults who use cannabis daily or near-daily will receive one of the drugs in the emergency room. The goal is to find the most effective treatment for these symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABINOID HYPEREMESIS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mercy Saint Vincent Medical Center
RECRUITINGToledo, Ohio, 43608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.